Chief Strategist, Biostatistics and Protocol Design
Rho, Inc
Durham, North Carolina
Ben Vaughn, Chief Strategist Biostatistics and Protocol Design, has demonstrated leadership excellence in the industry for more than 20 years. In his role, he utilizes his extensive expertise to guide sponsors through marketing applications, regulatory interactions, and the design and analysis of analgesia trials. Mr. Vaughn has supported more than 75 pain trials, 30+ marketing applications, and 6 FDA advisory committee meetings (both back room and bullpen) over the course of his career. He has represented sponsors in more than 50 Type A/B/C meetings with FDA.
Disclosure information not submitted.